Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 06:04 am Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Nikko Asset Management Americas Inc. | 1,357,472 5.15% | 1,357,472 (New Position) | View |
| 2022-02-11 09:40 am Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | STATE STREET CORP STT | 2,056,074 7.8% | 2,056,074 (New Position) | View |
| 2022-02-09 2:03 pm Sale | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,472,630 9.38% | -380,628 (-13.34%) | View |
| 2022-02-04 06:05 am Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Sumitomo Mitsui Trust Holdings Inc. | 1,357,472 5.14% | 1,357,472 (New Position) | View |
| 2022-02-03 4:41 pm Sale | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BlackRock Inc. BLK | 1,759,590 6.7% | -22,365 (-1.26%) | View |
| 2021-11-09 12:03 pm Sale | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,853,258 10.84% | -1,105,761 (-27.93%) | View |
| 2021-10-26 4:44 pm Sale | 13D | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Ultragenyx Pharmaceutical Inc. RARE | 1,200,000 4.6% | -200,000 (-14.29%) | View |
| 2021-08-12 5:09 pm Sale | 13D | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Ultragenyx Pharmaceutical Inc. RARE | 1,400,000 5.3% | -800,000 (-36.36%) | View |
| 2021-02-16 4:33 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 3,959,019 15.31% | 1,463,177 (+58.62%) | View |
| 2021-02-16 3:09 pm Sale | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Cormorant Asset Management LP | 0 0% | -1,144,537 (Position Closed) | View |
| 2021-02-16 12:24 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | PRICE T ROWE ASSOCIATES INC | 1,422,179 5.4% | 1,422,179 (New Position) | View |
| 2021-02-12 4:09 pm Sale | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | HealthCor Management L.P. | 0 0% | -1,584,466 (Position Closed) | View |
| 2021-02-02 3:13 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BlackRock Inc. BLK | 1,781,955 6.9% | 1,781,955 (New Position) | View |
| 2021-01-08 2:00 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | FEDERATED HERMES INC. FHI | 3,452,810 13.35% | 3,452,810 (New Position) | View |
| 2020-12-10 4:51 pm Sale | 13D | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Ultragenyx Pharmaceutical Inc. RARE | 2,200,000 9% | -800,000 (-26.67%) | View |
| 2020-10-09 1:41 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,495,842 10.23% | 1,112,086 (+80.37%) | View |
| 2020-09-11 4:00 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | HealthCor Management L.P. | 1,584,466 6.5% | 1,584,466 (New Position) | View |
| 2020-05-22 5:21 pm Purchase | 13D | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Ultragenyx Pharmaceutical Inc. RARE | 3,000,000 14.6% | 321,964 (+12.02%) | View |
| 2020-04-27 4:05 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Cormorant Asset Management LP | 1,144,537 5.76% | 1,144,537 (New Position) | View |
| 2019-06-25 6:17 pm Purchase | 13D | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Ultragenyx Pharmaceutical Inc. RARE | 2,678,036 19.99% | 2,678,036 (New Position) | View |